Janoudi, T., Jagdale, M., Wu, M., Gorlla, S., Zhang, P., Shao, Y., . . . Chang, K. Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies. Elsevier.
Chicago Style (17th ed.) CitationJanoudi, Tusneem, et al. Nonclinical Evaluation of HBG1/2 and BCL11A as Genome-editing Targets for the Treatment of β-hemoglobinopathies. Elsevier.
MLA (9th ed.) CitationJanoudi, Tusneem, et al. Nonclinical Evaluation of HBG1/2 and BCL11A as Genome-editing Targets for the Treatment of β-hemoglobinopathies. Elsevier.
Warning: These citations may not always be 100% accurate.